Hydroquinidine demonstrates remarkable antineoplastic effects on non-small cell lung cancer cells.

Our findings suggest that HQ has the potential to limit lung cancer growth as a novel potent anticarcinogenic agent. However, more investigations are needed to gain further insight into the mechanism of action of HQ and to evaluate its efficacy in in-vivo models.